When OCA moves to the front of the queue

A previous cartilage procedure that has not held leaves patients in a frustrating position: symptoms have returned, the joint has not recovered as expected, and the question becomes what the realistic next step looks like. For a specific group of patients, that next step is osteochondral allograft (OCA) transplantation — but it reaches the front of the queue only when certain clinical criteria are met, not simply because an earlier operation has failed.

Defect size is the most important of those criteria. Marrow-stimulation techniques such as microfracture and cell-based approaches such as ACI or MACI tend to produce inferior long-term results once a lesion exceeds roughly 2–4 cm². The salvage OCA literature reflects this clearly: in a systematic cohort of 164 knees treated with OCA after prior subchondral surgery, the mean defect size was 6.3 cm² — well into territory where smaller-scale repairs are unlikely to hold.

The biological landscape after a failed microfracture is also relevant. Drilling through the subchondral plate — and the subsequent breakdown of fibrocartilage fill — alters the structural environment in ways that make re-applying a cell-based scaffold less viable. OCA addresses this directly by reconstructing both the cartilage surface and the underlying bone in a single procedure, using living donor tissue.

Age adds another dimension. The same cohort had a mean age of 32.6 years — patients for whom total knee replacement would be premature and ideally avoided for decades. In this context, OCA functions as a joint-preservation strategy rather than a cure, with the realistic aim of restoring function for daily activities and low-impact sport while deferring arthroplasty.

What OCA actually reconstructs — and why that matters after prior surgery

Think of the knee's articular surface as a layered structure: hyaline cartilage on top, specialised subchondral bone immediately beneath. Effective reconstruction after a large or deep defect requires both layers to be addressed together — and that is precisely what OCA provides. A surgeon removes the damaged tissue down to healthy bone and replaces it with a precisely sized plug of donor bone and hyaline cartilage, shaped to match the defect contour. This is structural replacement from the base up, comparable to filling a pothole all the way down to the road foundation rather than simply resurfacing the top layer. Cell-based techniques and scaffolds work at the surface; OCA restores the full depth.

The distinction between fresh and frozen allograft matters here. Frozen tissue loses most of its chondrocyte viability during the banking process; fresh OCA preserves living, functional chondrocytes within the graft matrix. Those viable cells enable durable integration rather than simple mechanical fill — the graft incorporates into the joint rather than remaining an inert insert. It is this biological quality that underpins OCA's long-term track record in complex cases.

Anatomically, OCA can be applied at the femoral condyle, tibial plateau, and patellofemoral joint — a breadth documented in published series including a 2019 systematic review of patellofemoral outcomes (Chahla et al., AJSM 2019). In the salvage setting this matters directly: prior cartilage surgery may have affected any of these locations, and the anatomical site of a previous failed repair does not in itself close off the OCA option.

The clinical profile of patients who reach OCA

Patients who reach OCA after a failed previous procedure tend to share a recognisable clinical profile, even when the underlying diagnosis differs. In published salvage series, the leading cause is posttraumatic cartilage loss — accounting for around 38% of cases — followed by osteochondritis dissecans (30%), osteonecrosis (12%), and idiopathic causes (11%). This spread confirms that OCA is not a procedure reserved for one diagnostic group; it spans the full range of complex focal knee pathology.

The joint environment these patients present with is rarely straightforward. Nearly half — 46% in the Gracitelli series of 164 knees — required concomitant procedures at the time of OCA: meniscal repair, ligament reconstruction, or an osteotomy to correct alignment. Far from signalling elevated risk, this reflects the thoroughness with which complex cases are addressed in a single operative episode. An alignment osteotomy reduces the load through a repaired compartment and is routinely staged with or combined alongside OCA when varus or valgus malalignment would otherwise compromise graft longevity.

On defect size, the SUMMIT multicentre randomised trial established that lesions of 3 cm² or more derive meaningful benefit from advanced cartilage repair rather than marrow stimulation alone. Salvage OCA candidates typically sit well above even that threshold — the territory where autograft volume would fall short and a fresh allograft becomes the practical option.

What the evidence actually shows

Published data on OCA in the salvage setting is reassuringly consistent, even though no two studies capture quite the same population.

In the Gracitelli cohort of 164 knees — all treated with OCA after a prior subchondral procedure had failed — 86 in every 100 patients reported overall satisfaction with the outcome. Sixty-five per cent showed little or no arthritis at final follow-up, and the short-term complication rate was 2.4%. The failure rate, however, was 18%: roughly one patient in five ultimately did not retain a functioning graft. That figure warrants plain acknowledgement rather than qualification. In a cohort whose mean age was 32.6 years, the realistic alternative to OCA is not another cartilage repair but eventual knee replacement — a substantially larger intervention in a relatively young joint. Against that benchmark, an 18% failure rate in a surgically complex salvage population remains clinically defensible, but patients should understand it going in.

Functional recovery, where the graft holds, compares favourably. In a separate 149-knee series followed to a mean of six years, 75.2% of patients returned to sport or recreational activity, 71% achieved 'very good' or 'excellent' function on IKDC scoring, and 79% were able to participate at high activity levels.

For durability beyond the medium term, two anchoring studies are frequently cited. Gross et al. (Clin Orthop Relat Res 2008) documented long-term outcomes specifically in posttraumatic knee defects — the largest and most structurally compromised presentations. Raz et al. (JBJS 2014) reported results at a mean follow-up of 22 years in distal femoral OCA, providing some of the longest outcome data available for any cartilage restoration technique. Neither series suggests the graft is permanent by design, but both support OCA as a genuinely joint-preserving option rather than a bridge measured in months.

Recovery timeline and realistic goals after salvage OCA

Recovery from OCA follows a staged arc that reflects graft biology rather than simple wound healing. Low-impact activity — walking normally, swimming, cycling — is typically achievable from four to six months post-operatively, once early integration has been confirmed and the rehabilitation programme permits progressive loading. A return to higher-impact sport or recreational activity requires nine to twelve months, allowing sufficient time for the graft to consolidate within the recipient site and tolerate the mechanical demands of more vigorous movement.

Where concomitant procedures have been performed at the same operative episode — meniscal repair, ligament reconstruction, or an alignment osteotomy — the rehabilitation timeline extends accordingly. This is not a complication of a more complex case; it is the cost of addressing the mechanical environment that will protect the graft for the long term. A technically successful OCA in a malaligned joint without correction of that alignment is a graft under avoidable stress from day one.

Reframing the goal — and why that matters

The most important conversation a patient can have before salvage OCA is about what a successful outcome actually looks like. When OCA follows a procedure that has already failed, the clinical goal appropriately shifts: the priority becomes delaying or avoiding total knee arthroplasty and restoring reliable function in daily life and low-impact activity — not guaranteed return to high-level competitive sport.

This is not a lowering of expectations. It is an honest reading of where the patient is starting from. A joint that has undergone prior surgery, developed subchondral change, and required a complex reconstruction is not the same baseline as a first-time cartilage repair in an otherwise healthy knee. Setting the aim at joint preservation and functional independence is both medically accurate and, for most patients in this situation, a meaningful and achievable target.

The shift in framing also matters for graft durability. Patients who calibrate their activity levels to what the reconstructed joint can support — and who comply with the staged rehabilitation protocol — give the graft the best chance of lasting. That is the practical implication of honest pre-operative counselling, not pessimism.

Practical constraints and the escalation pathway if OCA fails

Fresh OCA requires living donor tissue — not frozen — which means tissue-bank sourcing and recipient scheduling must be coordinated before surgery can proceed. That process typically takes several weeks rather than days, and patients planning around work or caring commitments benefit from building this into their timeline from the point of decision.

If a primary OCA does not hold, the pathway has a documented next step. Horton et al. (AJSM 2013) established that revision OCA — a repeat allograft after prior OCA failure — can be viable in selected patients. It is more technically demanding and carries greater uncertainty than the primary procedure, but it confirms that the surgical route does not simply terminate at one graft failure.

When revision OCA is not viable — because of bone stock loss, age, or diffuse joint deterioration — total knee replacement is the realistic progression. The entire logic of OCA in a young joint is to defer that step by the longest margin the biology will sustain.

For patients weighing this decision after a failed prior procedure, OCA represents the most structurally complete restorative option available for large, subchondral-compromised lesions, with long-term evidence and an outcome profile that is clinically defensible relative to early arthroplasty. Assessing individual suitability requires a full joint-preservation workup; MSK Doctors consultants undertake this without referral across clinics in Sleaford and Grantham, with appointments available at mskdoctors.com.

1. [1] Articular cartilage damage — Wikipedia. https://en.wikipedia.org/wiki/Articular_cartilage_damage https://en.wikipedia.org/wiki/Articular_cartilage_damage